Concepedia

Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas

Mrinal M. Gounder, Ved Desai, Deborah Kuk, Narasimhan P. Agaram, Maria E. Arcila, Benjamin H. Durham, Mary Louise Keohan, Mark A. Dickson, Sandra P. D’Angelo, Neerav Shukla,

European Journal of Cancer · 2015 · 95 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Recurrent BRAF mutations in Langerhans cell histiocytosis

Gayane Badalian‐Very, Jo‐Anne Vergilio, Barbara Degar et al. · Blood · 2010 · 1.2K citations

, , +10

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Julien Haroche, Frédéric Charlotte, Laurent Arnaud et al. · Blood · 2012 · 693 citations

, , +10

Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases

Stefano Pileri, Thomas M. Grogan, Nancy L. Harris et al. · Histopathology · 2002 · 664 citations

, , +17

<i>BRAF-V600E</i> expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

Marie‐Luise Berres, Karen Phaik Har Lim, Tricia Peters et al. · The Journal of Experimental Medicine · 2014 · 436 citations · Full text

, , +13

Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis

Rikhia Chakraborty, Oliver Hampton, Xiaoyun Shen et al. · Blood · 2014 · 426 citations · Full text

, , +16